Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy
Clinical trial NCT04494113 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04494113
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-08
- Primary completion
- 2026-11-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.